Evidence map›Paper›PMID 32891579›Full record

ArticleAnales de pediatria2020

[COVID-19 and Africa: Surviving between a rock and a hard place].

Maite de Aranzabal, Victoria Fumadó, Iñaki Alegria, Mercedes Rivera, Nuria Torre, Belen Guibert, María José Muñoz, Cinta Moraleda, Quique Bassat, en representación del Grupo de Cooperación internacional de la Asociación Española de Pediatría (AEP)

Abstract read
In one paragraph

Article in Anales de pediatria, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maite de AranzabalCentro Salud Lakua Arriaga, Vitoria, Álava, España; Servicio de Urgencias IMQ Bilbao, Bilbao, Vizcaya, España.
Victoria FumadóISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, España; Unidad de enfermedades infecciosas pediátricas, Departamento de pediatría, Hospital Sant Joan de Déu (Universidad de Barcelona), Barcelona, España.
Iñaki AlegriaGambo General Rural Hospital, Oromiya, Etiopía; Departamento de Pediatría, Hospital General de Granollers, Universitat Internacional de Catalunya, Barcelona, España; Departamento de Pediatría, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, España.
Mercedes RiveraUGC de Pediatría y Neonatología, Hospital de la Axarquía, Málaga, España; Departamento de Farmacología y Pediatría Universidad de Málaga, Málaga, España.
Nuria TorreSEM pediátrico y neonatal, Hospital Sant Joan de Déu, Barcelona, España; Fundación Vicente Ferrer, RDT, Anantapur, India.
Belen GuibertUrgencias de Pediatría y Transporte Neonatal, Hospital General de Alicante, Alicante, España.
María José MuñozSección Infectología Pediátrica, Servicio de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, España.
Cinta MoraledaUnidad de Enfermedades Infecciosas Pediátricas, Departamento de Pediatría, Hospital Universitario 12 de Octubre, Madrid, España; Instituto de Investigación Sanitaria 12 de Octubre (IMAS12), Fundación para la Investigación Biomédica del Hospital 12 de Octubre, Madrid, España.
Quique BassatISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, España; Unidad de enfermedades infecciosas pediátricas, Departamento de pediatría, Hospital Sant Joan de Déu (Universidad de Barcelona), Barcelona, España; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; ICREA, Barcelona, España; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, España. Electronic address: quique.bassat@isglobal.org.
en representación del Grupo de Cooperación internacional de la Asociación Española de Pediatría (AEP)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With over 575,000 deaths and about 13.3 million cases globally, the COVID-19 pandemic has had a terrible impact globally during the 6 months since cases were first detected in China. Conscious of the many challenges presented in settings with abundance of resources and with robust health systems, where mortality has been significant and transmission difficult to control, there was a logical concern to see how the virus could impact African countries, and their fragile and weak health systems. Such an anticipated "tsunami", with potentially devastating consequences, seems however to not have yet arrived, and African countries, albeit witnessing an increasing degree of autochthonous transmission, seem to this day relatively unaffected by the pandemic. In this article we review the current situation of the pandemic in the African continent, trying to understand the determinants of its slow progress.

Indexed as

AfricaCOVID-19Delivery of Health CareDeveloping CountriesHealth ResourcesHumansAfricaÁfricaCOVID-19EpidemiologíaEpidemiologyLow-income countriesPaíses de baja rentaPandemiaPandemic

Identifiers

PMID32891579
PMCPMC7396975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.